TNGX
Tango Therapeutics, Inc.Company with tickers: TNGX
CIK
1819133
CUSIP
87583X109
Shares Outstanding
144,647,982
Website
https://www.tangotx.com
13F Activity (30d)
3 filings
2 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Sung Lee | member of the Nominating and Corporate Governance Committee of the Board | Appointed | 2026-05-13 |
| Sung Lee | Chairperson of the Compensation Committee | Appointed | 2026-05-13 |
| Sung Lee | Lead Independent Director of the Board | Appointed | 2026-05-13 |
| Kanishka Pothula | member of the Nominating and Corporate Governance Committee of the Board | Resigned | 2026-05-13 |
| Kanishka Pothula | Board | Resigned | 2026-05-13 |
| Alexis Borisy | Chairperson of the Compensation Committee of the Board | Resigned | 2026-05-13 |
| Alexis Borisy | Lead Independent Director of the Board | Resigned | 2026-05-13 |
| Alexis Borisy | Board of Directors | Resigned | 2026-05-13 |